The Effect of Counseling and Treatment Reminder Tool to Adherence with Drug and Outcome Clinic Patients with Diabetes Mellitus and Hypertension
Abstract
The World Health Organization declares Diabetes Mellitus and Hypertension as one of the health
emergencies. Adherence to medication is an important factor in controlling this disease. Research is needed to find out the combination of counseling and treatment reminder aids will aff ect adherence and clinical outcomes. Pretest-posttest design was conducted in February 2019 - May 2019. Sample population was Prolanis patients at Puskesmas Kembaran I, Purwokerto Timur II and Sumbang I. The inclusion criteria were 66 patients with type 2 diabetes and 72 patients with hypertension. The determination of the pretest-posttest group was by simple random sampling. The adherence instrument used MARS, counseling and medication reminder tools according to pharmaceutical counseling guidelines. The respondents were women, low education, normal BMI, didn’t work, combination of Diabetes medication and single medication for Hypertension. The pretest group was categorized as non-adherent, but experienced an increase after the intervention. The interventions given also had an eff ect on improving medication adherence and controlling the clinical outcome of type 2 DM patients and hypertensive patients at the Puskesmas (p-value 0,000 <0.05). The combination of pharmacist counseling interventions with medication reminders is more eff ective in increasing medication adherence in patients with type 2 Diabetes mellitus and Hypertension.
References
diseases. Switzerland: World Health Organization;
2014.
2. Williams R, Colagiuri S, Almutairi R, Montoya PA,
Abdul B, Beran D, et al. IDF DIABETES ATLAS. 9th
ed. International Diabetes Federation; 2019.
3. Balitbangkes. Laporan Nasional Riskesdas 2018
[Internet]. Lembaga Penerbit Badan Penelitian dan
Pengembangan Kesehatan; 2019. Available from:
http://labdata.litbang.kemkes.go.id/ccount/click.
php?id=19
4. Peltzer K, Pengpid S. The Prevalence and Social
Determinants of Hypertension among Adults in
Indonesia: A Cross-Sectional Population-Based
National Survey. International Journal of Hypertension.
2018:1–9.
5. Yap AF, Thirumoorthy T, Kwan YH. Medication
adherence in the elderly. Journal of Clinical
Gerontology and Geriatrics.2016.7(2):64–7.
6. Khunti K, Seidu S, Kunutsor S, Davies M. Association
Between Adherence to Pharmacotherapy and
Outcomes in Type 2 Diabetes: A Meta-analysis. Dia
Care.2017.40(11):1588–96.
7. Abebe SM, Berhane Y, Worku A, Getachew A.
Prevalence and Associated Factors of Hypertension: A
Crossectional Community Based Study in Northwest
Ethiopia. PLoS ONE. 2015.10(4):e0125210.
8. Verhulst MJL, Loos BG, Gerdes VEA, Teeuw WJ.
Evaluating All Potential Oral Complications of
Diabetes Mellitus. Front Endocrinol.2019.10:56.
9. Yudia N, Syafrita Y MR. Artikel penelitian perbedaan
fungsi kognitif antara pasien diabetes melitus
di rsup dr m djamil padang. Jurnal Kesehatan
Andalas.2017.6(2):311–7.
10. Sharp SI, Aarsland D, Day S, Sønnesyn H, Ballard
C. Hypertension is a potential risk factor for vascular
dementia: systematic review. Int J Geriat Psychiatry.
2011.26(7):661–9.
11. Yap AF, Thirumoorthy T, Kwan YH. Medication
adherence in the elderly. Journal of Clinical
Gerontology and Geriatrics.2016.7(2):64–7.
12. Paraidathathu T, Azuana, Islahudin F, Ahmad.
Medication adherence in patients with type 2 diabetes
mellitus treated at primary health clinics in Malaysia.
PPA.2013:525.
13. Nieuwlaat R, Wilczynski N, Navarro T, Hobson
N, Jeff ery R, Keepanasseril A, et al. Interventions
for enhancing medication adherence. Cochrane
Database of Systematic Reviews [Internet] 2014
[cited 2020 Oct 6];Available from: http://doi.wiley.
com/10.1002/14651858.CD000011.pub4
14. Galistiani GF, Wibowo MINA, Gladiwati R,
Merishandy D. Satisfaction’s Level of Hypertensive
Patients towards Pharmacy Counseling with
Al-Quran Based at Karya Sehat Pharmacy in
Purwokerto, Banyumas Regency. Indones J Clin
Pharm.2018.7(1):38–44.
15. Najiha MR, Utaminingrum W, Wibowo MINA. Peran
Home pharmacy care Pada Pasien Diabetes Mellitus
Tipe II Prolanis Terhadap Tingkat Kepatuhan dan
Keberhasilan Terapi di BP Sentra Medika Lebaksiu
Tegal. J Trop Pharm Chem. 2017.4(2):60–5.
16. Alfian R, Maulan A, Putra P. Uji Validitas Dan
Reliabilitas Kuesioner Medication Adherence Report
Scale (Mars) Terhadap Pasien Diabetes Mellitus.
Jurnal Ilmiah Ibnu Sina. 2017.2:176–83.
17. Muchid A, Wurjati W, Meutia F, Rahim R, Komar Z.
Pedoman Konseling Pelayanan Kefarmasian di Sarana
Kesehatan. Jakarta: Dirjen Bina Kefarmasian dan Alat
Kesehatan; 2007.
18. Tandra H. Life healthy with diabetes cetakan 1.
Yogyakarta: Rapha Publishing; 2013.
19. Anonim. Pedoman teknis penemuan dan
tatalaksana hipertensi. 1st ed. Jakarta: Departemen
Kesehatan RI; 2015.
20. Isnaini N R. Faktor risiko mempengaruhi kejadian
Diabetes mellitus tipe dua. Jurnal Keperawatan dan
Kebidanan Aisyiyah.2018;14(1):59–68.
21. Anonim. Petunjuk teknis pengukuran faktor resiko
diabetes melitus. Jakarta: Departemen Kesehatan RI;
2008.
22. Ramdhani J, Yetti K HT. Karakteristik dan gaya hidup
pasien hipertensi di rumah sakit al islam bandung. Global
Medical and Health Communication.2013.1(2):63–7.
23. Al-Rasheedi A. The role of educational level in
glycemic control among patients with type II diabetes
mellitus. Int J Health Sci (Qassim).2014.8(2):177–87.
24. Anggara D PN. Faktor-faktor yang berhubungan
dengan tekanan darah di puskesmas telaga murni
cikarang barat. Jurnal Ilmiah Kesehatan.2013.
5(1):20–5.
25. Sulistyarini ML ST. Dukungan keluarga meningkatkan
kepatuhan diet pasien diebetes mellitus di ruang rawat
inap rs baptis kediri. Jurnal STIKES.2013.6(1).
26. Mahler C, Herman K, Horne R et al. Assessing
reported adherence to pharmacological treatment
recommendations. translation and evaluation of
the medication adherence report scale (MARS) in
germany. Journal of Evaluation in Clinical Practice.
2010.16:574–9.
27. Icwari NPWP, Wirasuta IMAG SN. Akseptabilitas
pelayanan residensial kefarmasian pada pasien
diabetes mellitus tipe II tanpa komplikasi. Jurnal
Universitas Udayanaayana.2012:1–6.
176 WIBOWO ET AL. Jurnal Ilmu Kefarmasian Indonesia
28. Rasdianah N, Martodiharjo S, Andayani T, Hakim L.
The Description of Medication Adherence for Patients
of Diabetes Mellitus Type 2 in Public Health Center
Yogyakarta. Indones J Clin Pharm.2016.5(4):249–57.
29. E R, SR R, Rani V. Impact Of Continuous Patient
Counselling on Knowledge, Attitude, and Practices
And Medication Adherence of Diabetic Patients
Attending Outpatient Pharmacy Services. Asian J
Pharm Clin Res.2015:9(1).
30. Nugraheni AY, Sari P AT. Pengaruh konseling
apoteker dengan alat bantu pada pasien diabetes
melitus. Jurnal Manajemen dan Pelayanan Farmasi.
2015.5(4):233–40.
31. Atik A. Adherence to the australian national inpatient
medication chart : the effi cacy of a uniform national
drug chart on improving prescription eror. Jurnal of
Evaluation in Clinical Practice.2019.19:1–4.
32. Ariyani H, Dedi H AL. Kepatuhan pasien hipertensi
setelah pemberian pill card di rs x banjarmasin. Jurnal
of Current Pharmaceutical Sciences. 2018.1(2):81–8.
33. Nadia H, Murti AT CW. Pengaruh konseling farmasis
terhadap kepatuhan penggunaan obat serta hasil
terapi pasien diabetes melitus. The 5th Urecol
Proceding.2017.2:623–30.
34. Malathy R, Narmadha MP, Alfi n JM et al. Eff ect
of a diabetes counseling programme on knowledge,
attitude and practice among diabetic patients in erode
district of south india. Journal of Young Pharmacists.
2011.3(1):65–72.
35. Febriyanti Y, Murti AT CW. Pengaruh konseling
apoteker terhadap tingkat kepatuhan dan hasil terapi
pasien rawat jalan di poliklinik penyakit dalam. Jurnal
Manajemen dan Pelayanan Farmasi. 2013.3(4):311–7.
36. Kressin NR, Fei W, Judith L et al. Hypertensive
patients race, health beliefs, process of care, and
medication adherence. Society of General Internal
Medicine. 2007.22:768–74.
37. JNC. The seventh report of joint national committee
on prevention, detection, evaluation and treatment of
high blood pressure. US: Department of Health and
Human Services; 2013.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.
This licence applies to Author(s) and Public Reader means that the users mays :
- SHARE:
copy and redistribute the article in any medium or format - ADAPT:
remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication) - ALIKE:
If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original. - NO ADDITIONAL RESTRICTIONS:
You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
It does however mean that when you use it you must:
- ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
You may not:
- NONCOMMERCIAL: You may not use the article for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Tools
